Sep 22

Agenda – Tuesday September 22, 2026Tuesday, 22 September 2026

Showing 1 of 1 Streams

Networking Break

7:15am - 8:15am

Conference Registration and Continental Breakfast

Showing 1 of 1 Streams

General Session

8:15am - 8:30am

Informa Connect and Chairperson Welcome

Geoff Birkett - Chief Commercial Officer, Ensysce Biosciences

8:30am - 9:15am

Navigate the Shifting Terrain of Pharma and Biotech Commercialization

Dive into the latest trends shaping biotech commercialization, from market access hurdles to innovative pricing strategies and the critical role of pre-launch planning
Understand how to align portfolio strategy with market trends and unmet needs

Archana Sondhi - VP, Marketing and Commercial Strategy, IDEAYA Biosciences, Inc.
Laryssa Woznick - Senior Director, Market Development, Ardelyx
Jason M. Noto - Senior Vice President, US Market Access & Alliance Management, AVEO Oncology, An LG Chem Company

9:15am - 10:00am

Adapting Launch Strategies to Policy Shifts

Analyze Most Favored Nation policy implications and Inflation Reduction Act provisions that reshape market access and commercialization approaches
Examine regulatory compliance requirements and policy adaptation strategies for successful launches under evolving government controls
Develop stakeholder engagement tactics for interfacing with policymakers and advocacy groups to influence favorable policy conditions

Jennifer Snow - Founder, Apteka

Showing 1 of 1 Streams

Networking Break

10:00am - 10:30am

Networking and Refreshment Break

Showing 1 of 1 Streams

General Session

10:30am - 11:15am

Analyzing Strategic Pricing Models for Launch Success

Explore innovative pricing frameworks to align with market demands and payer expectations
Develop pricing strategies that ensure patient access while maintaining sustainable margins, addressing challenges in competitive and rare disease markets
Embed pricing considerations into pre-launch activities, including contracting strategies, payer negotiations and market access planning, to optimize launch outcomes

11:15am - 12:00pm

Orchestrating the Pre-Launch Symphony – Building Cross-Functional Harmony for Successful Launches

Implement strategic timelines for engaging with key stakeholders, including market access, trade, patient services, pricing/contracting, marketing, sales and operations, at optimal pre-launch intervals to maximize product value and ensure alignment across all functions
Foster collaboration between commercial, trade, and marketing teams to design effective distribution models that align with broader business objectives and customer needs
Highlight the importance of seamless communication and shared goals across marketing, sales, operations and other departments to drive a unified approach to pre-launch activities and ensure a successful product introduction

Keith White - Vice President, Market Access, Disc Medicine
German Guerrero - Executive Medical Director & Launch Lead, Atacicept – IgA Nephropathy, Vera Therapeutics

Showing 1 of 1 Streams

Networking Break

12:00pm - 1:00pm

Networking Luncheon

Showing 1 of 1 Streams

General Session

1:00pm - 1:45pm

Tailoring Launch Strategies for Rare Disease vs. Non-Specialty Markets

Design patient identification approaches that scale appropriately from the focused rare disease setting to broader specialty markets
Implement competitive positioning tactics that account for different stakeholder landscapes and treatment alternatives
Create resource allocation models that optimize investment across the different demands of rare and mainstream therapeutic areas

Ray Frost - Senior Vice President, Market Access, Cogent Biosciences
Sabrina McGuigan - Director, Franchise Operations, Global Rare Diseases, Sanofi
Abhishek (Abhi) Agrawal - Senior Director for Strategic Initiatives and Market Development, GSK

1:45pm - 2:30pm

Optimize Distribution Strategy for Commercial Success

Evaluate various distribution models, including specialty, open and limited distribution, with a focus on their operational and financial implications
Access the impact of distribution strategies on key stakeholders, such as manufacturers, specialty pharmacies, providers and payers, highlighting challenges like inventory management and patient access
Define KPIs and milestones to measure the effectiveness of distribution strategies and ensure continuous improvement

Charlie Strunck - Director of Market Access Oncology-Solid Tumor Franchise, BeOne Medicines USA, Inc.

2:30pm - 3:15pm

Navigating the AI Frontier—Embedding AI and Insights Across Launch Planning

Enhance forecasting, market segmentation and decision-making with AI-powered analytics to optimize launch strategies
Leverage AI tools to create tailored support programs, improve adherence and drive better treatment outcomes
Use real-time AI insights to monitor performance, adapt strategies and ensure sustained market success

Showing 1 of 1 Streams

Networking Break

3:15pm - 3:45pm

Networking and Refreshment Break

Showing 1 of 1 Streams

General Session

3:45pm - 4:30pm

Optimizing Gross-to-Net (GTN) and Financial Planning for Launch Success

Understand GTN dynamics and their impact on launch profitability
Uncover strategies for managing discounts, rebates and payer negotiations to optimize GTN outcomes
Benchmark on financial planning frameworks to align GTN with broader commercialization goals

Lydia Wu - Head of Finance, US, PharmaEssentia USA

4:30pm - 5:15pm

Building Sustainable Success Beyond Day One – Best Practices in the Post Launch Phase

Implement "watchtower" data aggregation systems for patient-level visibility into the treatment journey
Design cross-functional governance models to maintain launch-team integration well beyond initial market entry
Develop strategic approaches to hub program design that balance control requirements with access optimization
Create intervention protocols to quickly address reimbursement hurdles and access challenges as they emerge

Mayank Misra - VP Commercial Strategy, Analytics and Operations, Soleno Therapeutics

Showing 1 of 1 Streams

Networking Break

5:15pm - 6:15pm

Closing Summit Networking Reception